Somalogic Inc (SLGC)vsVeeva Systems Inc Class A (VEEV)
SLGC
Somalogic Inc
$9.85
0.00%
HEALTHCARE · Cap: $396.23M
VEEV
Veeva Systems Inc Class A
$184.15
-0.78%
HEALTHCARE · Cap: $30.46B
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 3810% more annual revenue ($3.20B vs $81.72M). VEEV leads profitability with a 28.4% profit margin vs -159.5%. VEEV earns a higher WallStSmart Score of 69/100 (B-).
SLGC
Avoid29
out of 100
Grade: F
VEEV
Strong Buy69
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for SLGC.
Margin of Safety
+29.2%
Fair Value
$249.97
Current Price
$184.15
$65.82 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Conservative balance sheet, low leverage
Keeps 28 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 29.4%
16.0% revenue growth
Earnings expanding 23.5% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -23.7% — below average capital efficiency
Revenue declined 47.1%
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : SLGC
SLGC has a balanced fundamental profile.
Bull Case : VEEV
The strongest argument for VEEV centers on Debt/Equity, Profit Margin, PEG Ratio. Profitability is solid with margins at 28.4% and operating margin at 29.4%. Revenue growth of 16.0% demonstrates continued momentum.
Bear Case : SLGC
The primary concerns for SLGC are EPS Growth, Market Cap, Return on Equity.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio.
Key Dynamics to Monitor
SLGC profiles as a turnaround stock while VEEV is a growth play — different risk/reward profiles.
SLGC carries more volatility with a beta of 1.64 — expect wider price swings.
VEEV is growing revenue faster at 16.0% — sustainability is the question.
VEEV generates stronger free cash flow (107M), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (69/100 vs 29/100), backed by strong 28.4% margins and 16.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?